Monitoring young people with type 1 diabetes for diabetic nephropathy: potential errors of annual ACR testing.
Oke J., Farmer A., Neil A., Dalton RN., Dunger D., Stevens R.
Type 1 diabetes guidelines recommend annual monitoring of albumin-creatinine ratio (ACR) to detect nephropathy. Annual monitoring for conditions such as dyslipidemia leads to high rates of false-positive diagnoses. We estimated rates of false-positive and false-negative diagnoses under annual, biennial and triennial monitoring.